Evidence map›Paper›PMID 42063701›Full record

ArticleFrontiers in oncology2026

Complementary and alternative medicine use among elderly cancer patients: a cross-sectional study in South Korea.

Hyunyem Chang, Soo Jeung Choi, Hyea Bin Im, Dain Choi, Dongwoon Han

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Hyunyem ChangVeterans Hospital System Medical Center, Seoul, Republic of Korea.
Soo Jeung ChoiDepartment of Global Health and Development, Graduate School, Hanyang University, Seoul, Republic of Korea.
Hyea Bin ImDepartment of Global Health and Development, Graduate School, Hanyang University, Seoul, Republic of Korea.
Dain ChoiDepartment of Global Health and Development, Graduate School, Hanyang University, Seoul, Republic of Korea.
Dongwoon HanDepartment of Global Health and Development, Graduate School, Hanyang University, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The use of complementary and alternative medicine (CAM) is common among elderly male cancer patients; however, evidence is limited on its prevalence, characteristics, and determinants in Korea. This study examined the prevalence, patterns, and reasons for CAM use, and identified factors associated with its use among elderly male cancer survivors. Materials and methods: A cross-sectional survey was conducted with 420 cancer patients aged ≥65 years attending outpatient clinics of the Veterans Hospital System, a 1,000-bed secondary hospital in Seoul, Korea. Data on CAM utilization, modalities, reasons for use, and information sources were collected using structured questionnaires. Multivariate logistic regression was used to identify demographic and clinical factors associated with CAM use. Results: Among participants, 60.0% reported using CAM. The most common modalities were exercise (brisk walking, 49.4%) and dietary interventions (42.9%). The primary reason for use was immune enhancement (61.6%), and family members or relatives were the main information source (42.1%). Multivariate analysis revealed that being married (OR 2.49, 95% CI 1.40-4.45), having prostate cancer (OR 2.14, 95% CI 1.36-3.35), and undergoing surgery (OR 1.62, 95% CI 1.07-2.45) were significantly associated with CAM use. Conclusion: CAM use is highly prevalent among elderly male Korean cancer patients, particularly among married men, prostate cancer patients, and those who have undergone surgery. Oncologists should incorporate discussions about CAM into survivorship care, and further studies are warranted to assess the impact of CAM modalities on quality of life and clinical outcomes.

Indexed as

agedcomplementary therapiescross-sectional studiesneoplasmsRepublic of Korea

Identifiers

PMID42063701
PMCPMC13124544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.